Indications for Breast Reduction in the Public Health Care System
NCT ID: NCT04889469
Last Updated: 2025-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2021-08-01
2031-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To examine the evidence for current national guidelines for breast reduction. The hypothesis is that BMI, breast volume, resection weight, and mental and physical symptoms affect the outcome of breast reconstruction, both in terms of complication risks, patient satisfaction and quality of life .
* To investigate which patients benefit the most from a breast reduction, in a health economic perspective. The starting point is that resources are limited and the purpose is to maximize the health effects for the patient at as low cost as possible. The hypothesis is that the health benefits, for the individual and society, are different depending on how big the breasts are and how much symptoms a patient has preoperatively.
* To examine back function and objective problems in women, with both natural and augmented breasts, with different body constitutions and volumes. The hypothesis is that a certain breast volume give rise to different physical symptoms in different women, depending on their other physical factors.
* To develop preferences for benign breast conditions that are treated in plastic surgery and for complications that the treatment can cause. Preferences are used to calculate QALY (quality-adjusted life years). Knowledge of preferences is essential for an analysis of healthcare needs.
* To examine women's experiences of how their breast hypertrophy affects them and their expectations of a breast reduction. The hypothesis is that the experience breast hypertrophy affects patients differently, and that expectations on a breast reduction can vary between different individuals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of Scales in Reconstructive Breast Surgery
NCT05233891
Reconstructions With Back Donor Site Flaps and Validation of Quality of Life Scales
NCT04526561
Effects of Expectations and Body Image in Breast Reconstruction
NCT04714463
Patient Preferences for Breast Reconstruction After Mastectomy
NCT01488357
Mapping Arterial Perforators Within the Breast During Mammoplasty
NCT06347952
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast hypertrophy operated
Women who have had a breast reduction in the public health care system
Breast reduction
Procedure to remove excess fat, tissue and skin from the breasts.
Breast hypertrophy controls
Women with symptoms of breast hypertrophy, who do not fulfill the requirements to have a breast reduction in the public health care system
No interventions assigned to this group
Augmented controls
Patients who have breast hypertrophy due to cosmetic breast augmentation
No interventions assigned to this group
The general public
Random sample of the general public
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breast reduction
Procedure to remove excess fat, tissue and skin from the breasts.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI\< 25 if under 50 years of age and BMI\<2 if over the age of 50
* Symptoms of breast hypertrophy
* Non-smokers
Un-operad controls:
-Symptoms of breast hypertrophy, but do not comply with the criteria above.
Augmented controls:
* Augmented breast volume \> 800 ml
* BMI\< 25 if under 50 years of age and BMI\<2 if over the age of 50
Exclusion Criteria
* Inability to understand the Swedish language
* Age under 18 years
18 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vastra Gotaland Region
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emma Hansson, PhD
Role: PRINCIPAL_INVESTIGATOR
Göteborg University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sahlgrenska university hospital
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Widmark-Jensen E, Bernhardsson S, Eriksson M, Hallberg H, Jepsen C, Jivegard L, Liljegren A, Petzold M, Svensson M, Warnberg F, Hansson E. A systematic review and meta-analysis of risks and benefits with breast reduction in the public healthcare system: priorities for further research. BMC Surg. 2021 Sep 11;21(1):343. doi: 10.1186/s12893-021-01336-7.
Related Links
Access external resources that provide additional context or updates about the study.
Health Technology Assessment (HTA) report 2021:121
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-01508
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.